Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001104659-20-138202

Options or other derivatives

  • Chief Executive Officer acquired 414,125 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Duncan Gregory Scott · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-21 Grant or award : show line 1 in the form Stock Option (right to buy) +414,125 414,125 D
Loading xslF345X03/tm2039099-4_4.xml…